Proteogenomic Characterization Reveals Subtype‐Specific Therapeutic Potential for HER2‐Low Breast Cancer
Year: 2025
Type: article
Language: en
Topic: HER2/EGFR in Cancer Research
Authors and affiliations:
raw_author_name: Shouping Xu
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
Key Laboratory of Tumor Biotherapy of Heilongjiang Province Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Keda Yu
raw_affiliation_strings: Department of Breast Surgery Shanghai Cancer Center and Cancer Institute Shanghai Medical College Fudan University  Shanghai 200032 China
raw_author_name: Lei Liu
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Qin Wang
raw_affiliation_strings: Heilongjiang Clinical Research Center for Breast Cancer Harbin Medical University Cancer Hospital  Harbin 150081 China
Key Laboratory of Tumor Biotherapy of Heilongjiang Province Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Xiaohui Wu
raw_affiliation_strings: Jingjie PTM Biolab (Hangzhou) Co. Ltd.  Hangzhou 310018 China
raw_author_name: Yihai Chen
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Guozheng Li
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Xin Zhang
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
Heilongjiang Clinical Research Center for Breast Cancer Harbin Medical University Cancer Hospital  Harbin 150081 China
Key Laboratory of Tumor Biotherapy of Heilongjiang Province Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Bo Wei
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Zitong Fu
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Abiyasi Nanding
raw_affiliation_strings: Department of Pathology Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Zuxianglan Zhao
raw_affiliation_strings: Jingjie PTM Biolab (Hangzhou) Co. Ltd.  Hangzhou 310018 China
raw_author_name: Lingbing Yang
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Xingda Zhang
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
Heilongjiang Clinical Research Center for Breast Cancer Harbin Medical University Cancer Hospital  Harbin 150081 China
Key Laboratory of Tumor Biotherapy of Heilongjiang Province Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Jianyu Wang
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
Heilongjiang Clinical Research Center for Breast Cancer Harbin Medical University Cancer Hospital  Harbin 150081 China
Key Laboratory of Tumor Biotherapy of Heilongjiang Province Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Wantong Sun
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Yi Hao
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Zhongyi Cheng
raw_affiliation_strings: Jingjie PTM Biolab (Hangzhou) Co. Ltd.  Hangzhou 310018 China
raw_author_name: Xiaojiang Cui
raw_affiliation_strings: Department of Surgery Samuel Oschin Cancer Institute Cedars‐Sinai Medical Center  Los Angeles CA 90048 USA
raw_author_name: Hao Wu
raw_affiliation_strings: Heilongjiang Clinical Research Center for Breast Cancer Harbin Medical University Cancer Hospital  Harbin 150081 China
Key Laboratory of Tumor Biotherapy of Heilongjiang Province Harbin Medical University Cancer Hospital  Harbin 150081 China
raw_author_name: Da Pang
raw_affiliation_strings: Department of Breast Surgery Harbin Medical University Cancer Hospital  Harbin 150081 China
Heilongjiang Clinical Research Center for Breast Cancer Harbin Medical University Cancer Hospital  Harbin 150081 China